ArticleLearning health systems2025
How an evidence synthesis program's growth has supported research use and learning community partnership networks within a learning health system: A descriptive analysis and case series.
Article in Learning health systems, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The Veterans Administration Evidence Synthesis Program (VA ESP) was established in 2007 to support evidence-based decisions about policies and programs in the VA healthcare system and has served as a critical component in the VA learning health system. Our objective was to document the growth of the ESP partner network and key policy and practice impacts of the program through a descriptive social network analysis and case series. We also aimed to provide insights into key features of some successful partnerships and the role evidence synthesis can play in supporting the improvement of the health system. Methods: Using social network analysis and national ESP program data, we depicted the network at its initial, fully operational, and established phases of development to describe over a decade of ESP partnerships. We also queried program leadership and ESP partners about their collaboration experiences to generate a case series that demonstrates key examples of successful partnerships. Results: Of the 82 partner offices for whom the ESP has generated a report, over half (66%, Conclusion: Partnerships between the ESP and decision-makers can facilitate access to evidence and leadership's ongoing use of this evidence. The ESP has led to meaningful, evidence-driven communication between research and operational partners and has supported stakeholders in informing policy and system change.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.